A team of scientists have developed new nano-mapping technology that could transform the way disease-causing genetic mutations are diagnosed and discovered.
Josiah Zayner, the scientist who left NASA to bring genetic engineering to consumers has modified his own genome with CRISPR (true DIY style).
Scientists have succeeded in developing a method to target a cell’s DNA or RNA, to shut down the production of a protein.
After receiving $19 million in series A funding, the biotech is taking steps towards their first clinical trial for CRISPR-based antimicrobial drugs.
George Church has published an opinion article today which argues that gene editing within the human germline should not be rejected out of hand
Keith Speights takes a look at four biotech companies that he believes are currently in the process of disrupting healthcare.
New delivery mechanism that includes nanoparticles completely turned off a gene responsible for high cholesterol in mice.
The revolutionary gene-editing tool, CRISPR, will grow into a $10 billion market by 20215, according to Citi GPS’ new report.